Statements (13)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:chemical_compound
|
| gptkbp:CASNumber |
1985606-14-1
|
| gptkbp:hasInChIKey |
gptkb:QJQYQKZDHGQXQJ-UHFFFAOYSA-N
|
| gptkbp:hasMolecularFormula |
C20H16F3N3O4S
|
| gptkbp:hasRole |
antiviral drug
|
| gptkbp:hasSMILES |
C1CC2=C(C1)C3=CC(=O)N(C4=CC=CC(=C34)N2)C(=O)OC(=O)C(F)(F)F
|
| https://www.w3.org/2000/01/rdf-schema#label |
baloxavir acid
|
| gptkbp:isActiveMetaboliteOf |
gptkb:baloxavir_marboxil
|
| gptkbp:IUPACName |
(12aR)-2,4-dioxo-1,2,3,4,12,12a-hexahydro-5H-benzo[4,5]cyclopenta[1,2-b]pyrido[3,4-e][1,4]oxazin-9-yl 2,2,2-trifluoroacetate
|
| gptkbp:molecularWeight |
415.42 g/mol
|
| gptkbp:target |
influenza cap-dependent endonuclease
|
| gptkbp:bfsParent |
gptkb:baloxavir_marboxil
|
| gptkbp:bfsLayer |
6
|